Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MarrowCHAMP: cBMA for BKA Wound Complications
NCT02863926Phase 1Completed
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial in critical limb ischemia (CLI) (3 arms). Primary endpoint: Number of Participants With Treatment-related Adverse Events at 12 months. Started Jan 2017; status: completed.
02
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02863926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863926.